We invest in institutional quality office, R & D, Life Science and industrial properties in the Western U.S. that appeal to today's modern tenants.
Since 2012, Graymark Capital has purchased 30 office, R&D, Life Science and industrial properties comprising over
3.5 million square feet and over $1.7 billion of value.